Mindful Diagnostics and Therapeutics (MD&T) employs extensive laboratory testing and other features of the MEND protocol, the ReCODE protocol and the Bredesen protocol; all developed by Dr. Dale Bredesen, a neurologist and author of the book “The End of Alzheimer’s”. Additionally MD&T provides further testing and coaching focusing on Alzheimer’s risk and education …
resulting in a personalized treatment program.
MD&T is intended for those who want to mitigate their risk of Alzheimer’s, those who carry genetic risk for Alzheimer’s (APOE4 gene and/or strong family history). Individuals who have been diagnosed with MCI (mild cognitive impairment) And those with early Alzheimer’s disease.
As Dr. Bredesen states in his book The End of Alzheimer’s — Alzheimer’s disease can be prevented and in many cases the symptoms can be reversed. We are so tainted by the lack of success in treating Alzheimer’s dementia that these bold words can only be viewed with skepticism. The science behind Mindful Diagnostics and Therapeutics suggests that a personalized program can prevent cognitive decline and, for those affected by early Alzheimer’s, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment) can restore their ability to remember, to think and live a brain healthy life.
Patients who experience or are diagnosed with any of the following are good candidates for the MEND Protocol:
—- Patient must be sober for at least 3 months
—- EX: vascular dementia, Parkinson’s disease, frontal temporal dementia
—- Both current and recurring
—- On 3 or more medications to treat
—- In need of counceling more than once a month
—- Currently having suicidal thoughts/ideations